MANILA – The Department of Health official (DOH) said Monday that the Philippines Food and Drug Administration (FDA) will withdraw drug maintenance for blood pressure if they are contaminated with harmful components.
"They (FDA) are already checking whether Sandoz Losartan is of this type in the Philippines. If so, they will (the drugs) be pulled out," said Under Secretary DOH Rolando Sunday at Philippine News Agency (PNA) in a text message.
Sandoz is the pharmaceutical company that produces Losartan, a famous maintenance drug used by many Filipinos with high blood pressure.
On November 8, the United States FDA announced a statement, saying that many pharmaceutical companies recall the Losartan Potassium Hydrochlorothiazide tables after tests show that it contains remnants of imperialization of the N-nitrosodiethylamine.
"This disorders, which are a naturally occurring substance in some foods, drinking water, air pollution and industrial processes, have been classified as a likely human carcinogen such as the International Agency for Cancer Research, "the statement reads. (PNA)